GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Cyclically Adjusted PB Ratio

Shire (SHPG) Cyclically Adjusted PB Ratio : (As of May. 05, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shire Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shire Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shire's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Cyclically Adjusted PB Ratio Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shire's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Shire's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shire's Cyclically Adjusted PB Ratio falls into.



Shire Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shire's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2018 is calculated as:

For example, Shire's adjusted Book Value per Share data for the three months ended in Sep. 2018 was:

Adj_Book=Book Value per Share/CPI of Sep. 2018 (Change)*Current CPI (Sep. 2018)
=122.302/101.3705*101.3705
=122.302

Current CPI (Sep. 2018) = 101.3705.

Shire Quarterly Data

Book Value per Share CPI Adj_Book
200812 6.951 99.875 7.055
200903 8.257 97.782 8.560
200906 8.400 96.287 8.843
200909 8.951 95.589 9.492
200912 10.219 94.892 10.917
201003 10.979 94.792 11.741
201006 11.305 95.490 12.001
201009 12.262 95.988 12.950
201012 13.081 96.187 13.786
201103 14.775 97.683 15.333
201106 15.554 98.081 16.076
201109 15.759 98.480 16.222
201112 16.987 98.480 17.486
201203 18.775 99.875 19.056
201206 19.290 99.676 19.618
201209 20.681 100.075 20.949
201212 20.316 99.676 20.661
201303 20.585 100.374 20.789
201306 20.435 100.374 20.638
201309 22.805 100.274 23.054
201312 27.560 99.875 27.973
201403 28.908 100.573 29.137
201406 30.682 100.773 30.864
201409 32.768 100.474 33.061
201412 44.161 99.576 44.957
201503 45.649 99.975 46.286
201506 46.289 100.573 46.656
201509 48.505 100.274 49.035
201512 49.764 99.676 50.610
201603 52.160 99.676 53.047
201606 99.453 101.072 99.747
201609 99.087 100.274 100.170
201612 96.045 99.676 97.678
201703 98.483 100.374 99.461
201706 103.424 100.673 104.141
201709 107.949 100.474 108.913
201712 119.433 100.075 120.979
201803 123.202 100.573 124.179
201806 120.750 101.072 121.107
201809 122.302 101.371 122.302

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shire  (NAS:SHPG) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shire Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shire's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines